FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
A major workforce optimisation programme has started at the Countess of Chester Hospital NHS Foundation Trust in partnership with workforce planning specialists, SARD.
Read more here.
Nursing education is really no longer limited to textbooks and clinical rotations. The accelerated embrace of digital technologies is transforming the way future nurses learn, with education becoming more accessible, flexible and interactive. Technology, ranging from AI-powered tutoring systems to…
Attendees
Sponsors and
Exhibitors
AI Training
for Doctors Workshops
Contact us